ITOC
iTonic Holdings Ltd.
NASDAQ: ITOC · HEALTHCARE · MEDICAL DEVICES
$0.31
+0.07% today
Updated 2026-06-03
Market cap
$6.92M
P/E ratio
—
P/S ratio
13.23x
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$0 – $1
Volume
4.1M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+5.5
Quality
C+2.5
Profitability
F5.0
Valuation
C+1/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Revenue growth 91.60% QoQ
Risks
- Piotroski 1/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-3.24M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $679777.00 | $628591.00 | $448196.00 | $523031.00 | $523030.00 |
| Net income | $83980.00 | $-241217.00 | $-660588.00 | $-5.10M | $-5.10M |
| EPS | — | — | — | — | $-0.32 |
| Free cash flow | $-116152.00 | $-63640.00 | $-775859.00 | $-3.24M | $-3.24M |
| Profit margin | 12.35% | -38.37% | -147.39% | -974.68% | — |
Peer comparison
Smart narrative
iTonic Holdings Ltd. trades at $0.31. Our Smart Value Score of 33/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. TTM revenue stands at $523030.00.
Frequently asked questions
What is iTonic Holdings Ltd.'s stock price?
iTonic Holdings Ltd. (ITOC) trades at $0.31, on a P/S of 13.2x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is iTonic Holdings Ltd. overvalued?
iTonic Holdings Ltd. carries a Smart Value Score of 33/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is iTonic Holdings Ltd.'s revenue?
iTonic Holdings Ltd.'s trailing twelve-month revenue is $523030.00. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio13.23x
ROE-71.30%
Beta—
50D MA$0.32
200D MA$0.51
Shares out0.01B
Float0.01B
Short ratio—
Avg volume4.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—